kras mutation and glutathion glynac Glutathione Depletion Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Isoform-Specific Destabilization of the Active – KRAS mutation: from undruggable to
KRAS mutation: from undruggable to druggable in cancer Signal Transduction and Targeted Therapy KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives Metabolic networks in mutant KRAS driven tumours: tissue specificities and the microenvironment Nature Reviews Cancer KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology
Pay in 4 interest-free payments of $6.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





